Pyroglutamylated RFamide Peptide (Human)
- Code:
- 4419-s
- Name:
- Pyroglutamylated RFamide Peptide (Human)
- QRFP (Human)
- Pyr-Asp-Glu-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Ala-Ala-Gly-Glu-Lys-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2
- (M.W. 4503.8) C199H301N55O65
- Endogenous Ligand for AQ27 / SP9155 / GPR103
- main
- more information
- reference
main
- Purity:
- ≧99.0% (HPLC)
- Storage:
- -20 ℃
- Production:
- Synthetic Product
Solubility: H2O (0.1 mM)
more information
- Category:
- Biologically Active Peptides
reference
- S. Fukusumi, H. Yoshida, R. Fujii, M. Maruyama, H. Komatsu, Y. Habata, Y. Shintani, S. Hinuma, and M. Fujino, J. Biol. Chem., 278, 46387 (2003). (Original)
- Y. Jiang, L. Luo, E.L. Gustafson, D. Yadav, M. Laverty, N. Murgolo, G. Vassileva, M. Zeng, T.M. Laz, J. Behan, P. Qiu, L. Wang, S. Wang, M. Bayne, J. Greene, F. Monsma, Jr., and F.L. Zhang, J. Biol. Chem., 278, 27652 (2003). (Orphan Receptor Ligand / 26-Residue Peptide, P518)
- N. Chartrel, C. Dujardin, Y. Anouar, J. Leprince, A. Decker, S. Clerens, J.-C. Do-Réo, F. Vandesande, C. Llorens-Cortes, J. Costentin, J.-C. Beauvillain, and H. Vaudry, Proc. Natl. Acad. Sci. U.S.A., 100, 15247 (2003). (26-Residue Peptide, 26RFa)
- S. Takayasu, T. Sakurai, S. Iwasaki, H. Teranishi, A. Yamanaka, S.C. Williams, H. Iguchi, Y.I. Kawasawa, Y. Ikeda, I. Sakakibara, K. Ohno, R.X. Ioka, S. Murakami, N. Dohmae, J. Xie, T. Suda, T. Motoike, T. Ohuchi, M. Yanagisawa, and J. Sakai, Proc. Natl. Acad. Sci. U.S.A., 103, 7438 (2006). (Pharmacol.)
- R. Moriya, H. Sano, T. Umeda, M. Ito, Y. Takahashi, M. Matsuda, A. Ishihara, A. Kanatani, and H. Iwaasa, Endocrinology, 147, 2916 (2006). (Pharmacol.)
- S. Fukusumi, R. Fujii, and S. Hinuma, Peptides, 27, 1073 (2006). (Review)
- D.A. Bechtold and S.M. Luckman, J. Endocrinol., 192, 3 (2007). (Review)
他の製品を検索する